Cristhiam Rojas Hernandez
Overview
Explore the profile of Cristhiam Rojas Hernandez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li A, De Las Pozas G, Andersen C, Nze C, Toale K, Milner E, et al.
Am J Hematol
. 2023 Apr;
98(7):1052-1057.
PMID: 37067102
Venous thromboembolism (VTE) is a significant complication for cancer patients undergoing systemic therapy. We performed an independent external validation for a recently derived and validated a novel electronic health record...
2.
Li A, Martens K, Nguyen D, Basom R, Rondon G, Jin S, et al.
Am J Hematol
. 2022 Mar;
97(6):740-748.
PMID: 35266218
In patients undergoing hematopoietic cell transplantation (HCT), venous thromboembolism (VTE) remains a serious complication that lacks validated risk assessment models (RAMs) to guide thromboprophylaxis. To address this dilemma, we performed...
3.
Martens K, Amos C, Rojas Hernandez C, Kebriaei P, da Costa Jr. W, Basom R, et al.
Am J Hematol
. 2021 Jun;
96(9):1137-1146.
PMID: 34097772
History of venous thromboembolism (VTE) is prevalent among patients undergoing hematopoietic cell transplantation (HCT). Management of anticoagulation is particularly challenging as most patients will have chemotherapy-induced thrombocytopenia while awaiting engraftment...
4.
Kraaijpoel N, Di Nisio M, Mulder F, van Es N, Beyer-Westendorf J, Carrier M, et al.
Thromb Haemost
. 2018 Jul;
118(8):1439-1449.
PMID: 30060256
In the Hokusai VTE Cancer study, edoxaban was non-inferior to dalteparin for the composite outcome of recurrent venous thromboembolism (VTE) and major bleeding in 1,050 patients with cancer-associated VTE. The...